0719 Share Price

Open 5.46 Change Price %
High 5.62 1 Day -0.04 -0.72
Low 5.46 1 Week -0.14 -2.47
Close 5.52 1 Month 0.23 4.35
Volume 272100 1 Year 1.54 38.69
52 Week High 6.40
52 Week Low 3.63
0719 Important Levels
Resistance 2 5.67
Resistance 1 5.61
Pivot 5.53
Support 1 5.43
Support 2 5.37
HKG HongKong Most Active Stocks
0364 0.03 -25.00%
0136 0.20 -20.00%
0566 3.91 0.00%
0061 0.02 0.00%
3988 3.51 -1.13%
0939 5.79 -1.03%
0381 0.08 0.00%
1076 0.15 0.00%
0030 0.15 7.14%
0261 0.01 0.00%
More..
HKG HongKong Top Gainers Stocks
2168 4.60 17.65%
0582 0.07 16.67%
8129 0.08 14.29%
0621 0.09 12.50%
2302 2.87 11.67%
2882 0.10 11.11%
8163 0.10 11.11%
3318 2.12 10.42%
8321 9.40 10.33%
8088 0.11 10.00%
More..
HKG HongKong Top Losers Stocks
4338 80.00 -38.93%
4333 60.00 -25.00%
0364 0.03 -25.00%
0136 0.20 -20.00%
8351 0.10 -16.67%
8272 0.05 -16.67%
8002 4.00 -15.97%
8201 0.07 -12.50%
8262 0.89 -11.88%
0193 0.08 -11.11%
More..

Shandong Xinhua Pharmaceu (HKG: 0719)

0719 Technical Analysis 1.5
As on 20th Jan 2017 0719 Share Price closed @ 5.52 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.15 & Sell for SHORT-TERM with Stoploss of 5.65 we also expect STOCK to react on Following IMPORTANT LEVELS.
0719 Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
0719 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.xhzy.com
0719 Address
0719
No. 1 Lutai Avenue
Hi-Tech Industry Development Zone
Zibo City, 255086
China
Phone: 86 53 3219 6024
Fax: 86 53 3228 7508
0719 Latest News
'Bad news' is good news for Hong Kong equities   EJ Insight   - 11th Oct 16
BRIEF-Shandong Xinhua Pharma gets regulatory approval for private placemen...   Reuters   - 18th Mar 16
US FDA Inspections in China: An Analysis of Form 483s from 2015   Regulatory Focus   - 11th Feb 16
Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America ...   GlobeNewswire (press release)   - 11th Nov 15
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing ...   PR Newswire (press release)   - 07th Oct 15
Research and Markets: Global Ibuprofen Industry Report 2015-2020   Business Wire (press release)   - 09th Jan 15
China Chemical Pharmaceutical Industry Report, 2013-2016   PR Newswire (press release)   - 12th Dec 14
Research and Markets: China Chemical Pharmaceutical Industry Report 2014-2016 ...   Business Wire (press release)   - 01st Dec 14
Pharma Contract Manufacturing: World Market Outlook 2013-2023   PR Newswire (press release)   - 03rd Jun 14
Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs ...   PR Newswire (press release)   - 02nd Sep 13
Interactive Technical Analysis Chart Shandong Xinhua Pharmaceu ( 0719 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shandong Xinhua Pharmaceu
0719 Business Profile
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, is engaged in the development, manufacture, and sale of bulk pharmaceuticals, preparations, and chemical products. The company operates through Bulk Pharmaceuticals, Preparations, Chemical and other products, and Commerce circulations. It provides antipyretics and analgesics; and drugs for central nervous system, steroids, and cardio cerebrovascular systems, as well as finished dosage forms and pharmaceutical intermediates. The company offers its products in various dosages forms, such as tablets, capsules, injections, and ointments. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products. In addition, the company is involved in the retail and wholesale of pharmaceutical products, as well as offers building management services. It operates in the People's Republic of China, Europe, the United States, and internationally. The company was founded in 1943 and is based in Zibo City, the People's Republic of China.